Cargando…

Salmonella Breaks Tumor Immune Tolerance by Downregulating Tumor Programmed Death-Ligand 1 Expression

Immunotherapy is becoming a popular treatment modality in combat against cancer, one of the world’s leading health problems. While tumor cells influence host immunity via expressing immune inhibitory signaling proteins, some bacteria possess immunomodulatory activities that counter the symptoms of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Man-Chin, Pangilinan, Christian Ronquillo, Lee, Che-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017279/ https://www.ncbi.nlm.nih.gov/pubmed/31878272 http://dx.doi.org/10.3390/cancers12010057

Ejemplares similares

Salmonella-Based Targeted Cancer Therapy: Updates on A Promising and Innovative Tumor Immunotherapeutic Strategy
por: Pangilinan, Christian Ronquillo, et al.
Publicado: (2019)

Salmonella Overcomes Drug Resistance in Tumor through P-glycoprotein Downregulation
por: Yang, Chih-Jen, et al.
Publicado: (2018)

The extracts of Astragalus membranaceus overcome tumor immune tolerance by inhibition of tumor programmed cell death protein ligand-1 expression
por: Chang, Hsu-Liang, et al.
Publicado: (2020)

Downregulation of AKT/mTOR signaling pathway for Salmonella-mediated autophagy in human anaplastic thyroid cancer
por: Wu, Li-Hsien, et al.
Publicado: (2022)

Salmonella Impacts Tumor-Induced Macrophage Polarization, and Inhibits SNAI1-Mediated Metastasis in Melanoma
por: Pangilinan, Christian R., et al.
Publicado: (2021)

Salmonella overcomes tumor immune tolerance by inhibition of tumor indoleamine 2, 3-dioxygenase 1 expression
por: Kuan, Yu-Diao, et al.
Publicado: (2015)

Highlights of Immunomodulation in Salmonella-Based Cancer Therapy
por: Pangilinan, Christian R., et al.
Publicado: (2021)

Salmonella inhibits tumor angiogenesis by downregulation of vascular endothelial growth factor
por: Tu, Dom-Gene, et al.
Publicado: (2016)

Effects of Tumor-Derived Exosome Programmed Death Ligand 1 on Tumor Immunity and Clinical Applications
por: Shao, Bo, et al.
Publicado: (2021)

Salmonella reduces tumor metastasis by downregulation C-X-C chemokine receptor type 4
por: Lee, Tai-Huang, et al.
Publicado: (2021)

Hinokitiol reduces tumor metastasis by inhibiting heparanase via extracellular signal-regulated kinase and protein kinase B pathway
por: Wu, Yueh-Jung, et al.
Publicado: (2020)

Downregulations of AKT/mTOR Signaling Pathway for Salmonella-Mediated Suppression of Matrix Metalloproteinases-9 Expression in Mouse Tumor Models
por: Tsao, Yu-Tzu, et al.
Publicado: (2018)

Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors
por: Liu, Min, et al.
Publicado: (2020)

Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis
por: Vathiotis, Ioannis A., et al.
Publicado: (2021)

Programmed Cell Death Tunes Tumor Immunity
por: Liu, Jing, et al.
Publicado: (2022)

Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity
por: Hensel, Jonathan A., et al.
Publicado: (2018)

Eicosapentaenoic acids enhance chemosensitivity through connexin 43 upregulation in murine melanoma models
por: Yang, Chih-Jen, et al.
Publicado: (2019)

Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells
por: Gibbons Johnson, Rachel M., et al.
Publicado: (2017)

Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma
por: Lomphithak, Thanpisit, et al.
Publicado: (2021)

A critical role for the programmed death ligand 1 in fetomaternal tolerance
por: Guleria, Indira, et al.
Publicado: (2005)

Programmed death ligand 1 (PD-L1) expression in parathyroid tumors
por: Pan, Boju, et al.
Publicado: (2019)

Programmed Death-Ligand 1 Expression in Lymphovascular Tumor Emboli in Lung Cancer
por: Yeh, Yi-Chen, et al.
Publicado: (2022)

Inhibition of Tumor Growth Using Salmonella Expressing Fas Ligand
por: Loeffler, Markus, et al.
Publicado: (2008)

Breaking the tolerance for tumor: Targeting negative regulators of TLR signaling
por: Standiford, Theodore J., et al.
Publicado: (2012)

Programmed death‑ligand 1 expression in tumor cells and tumor‑infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer
por: Sangkhamanon, Sakkarn, et al.
Publicado: (2023)

Infiltration of tumor‐associated macrophages is involved in tumor programmed death‐ligand 1 expression in early lung adenocarcinoma
por: Shima, Toshiyuki, et al.
Publicado: (2020)

Association Between Intra-Tumoral Immune Response and Programmed Death Ligand 1 (PD-L1) in Gastric Cancer
por: Yan, Rong, et al.
Publicado: (2019)

Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
por: Xiang, Yuancai, et al.
Publicado: (2023)

Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay
por: Scorer, Paul, et al.
Publicado: (2018)

Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial Carcinoma
por: Chiang, Pei-Jhang, et al.
Publicado: (2021)

The role of the programmed cell death protein-1/programmed death-ligand 1 pathway, regulatory T cells and T helper 17 cells in tumor immunity: a narrative review
por: Zhang, Lanfang, et al.
Publicado: (2020)

Programmed death-ligand 1 (PD-L1) expression in various tumor types
por: Grosso, Joseph, et al.
Publicado: (2013)

Exosomes loaded with programmed death ligand-1 promote tumor growth by immunosuppression in osteosarcoma
por: Zhang, Lei, et al.
Publicado: (2021)

Downregulated TICAM1 is a prognostic biomarker and associated with immune tolerance of Wilms tumor patients
por: Lu, Zhiyi, et al.
Publicado: (2022)

Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth
por: Lee, Che-Hsin, et al.
Publicado: (2017)

Chemokine C‐C motif ligand 21 synergized with programmed death‐ligand 1 blockade restrains tumor growth
por: Chen, Qiangda, et al.
Publicado: (2021)

Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells
por: Yang, Mengqi, et al.
Publicado: (2017)

Glucose-6-phosphate dehydrogenase correlates with tumor immune activity and programmed death ligand-1 expression in Merkel cell carcinoma
por: Nakamura, Motoki, et al.
Publicado: (2020)

Clinical significance of programmed death‐1 and programmed death‐ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma
por: Mikami, Shuji, et al.
Publicado: (2019)

Current Landscape of Immunotherapy Trials Involving the Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Axis in Intrathoracic Tumors
por: Kareff, Samuel A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7u5j5gniek0oqlr7mbvvt0r3tc